title: Neuroleptic malignant-like syndrome due to donepezil and maprotiline.
authors.affiliation: Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan. ohkoshin@ md.tsukuba.ac.jp
authors.forename: Norio
authors.initials: N
authors.lastname: Ohkoshi
authors.forename: Daisuke
authors.initials: D
authors.lastname: Satoh
authors.forename: Masaaki
authors.initials: M
authors.lastname: Nishi
authors.forename: Shin'ichi
authors.initials: S
authors.lastname: Shoji
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D000077265:Donepezil; D004357:Drug Synergism; D006801:Humans; D007189:Indans / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008376:Maprotiline / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D010880:Piperidines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D018687:Antidepressive Agents, Second-Generation; D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D008376:Maprotiline; D000077265:Donepezil